Our CEO Simon Mølgaard was interviewed by Sejelas where he talks about Teitur Trophics and our commitment to developing novel treatments for treating patients suffering from neurodegenerative diseases.

You can read the full interview below:

https://sejelas.com/simon-molgaard/